THE USE OF PPAR-GAMMA AGONISTS FOR TREATING DISEASES CHARACTERISED BY NEURON DEGENERATION, NEURON INJURY OR IMPAIRED PASTICITY

摘要

A method for the promotion of growth and/or repair of neurons in diseases or conditions characterised by neuron degeneration, injury or impaired plasticity which method comprises the administration of an effective, non-toxic and pharmaceutically acceptable amount of a PPARη agonist or a pharmaceutically acceptable derivative thereof.